• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Year in Review: The 8 Most Important Lab Compliance Stories of 2023

Year in Review: The 8 Most Important Lab Compliance Stories of 2023

by Glenn S. Demby | Jan 9, 2024 | Elite, Inside the Lab Industry-lir, Lab Industry Advisor

Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: Key Lab Test Clearances of 2023

FDA Watch: Key Lab Test Clearances of 2023

by Glenn S. Demby | Jan 9, 2024 | Essential, FDA-lca, Lab Industry Advisor

G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Inside the Lab Industry: Q3 Earnings Signal Beginning of the End of ‘COVID-19 Hangover’

Inside the Lab Industry: Q3 Earnings Signal Beginning of the End of ‘COVID-19 Hangover’

by Glenn S. Demby | Jan 4, 2024 | Inside the Lab Industry-lir, Lab Industry Advisor, Premium

What 2023 Q3 earnings from 30 key US lab companies indicate about the current state of the industry and outlook for 2024.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
January 2024 Labs in Court

January 2024 Labs in Court

by Glenn S. Demby | Jan 2, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent cases involve Medicare’s 14-Day Rule, improper PHI disclosure to a media outlet, kickbacks, and COVID-19 fraud.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Lost Ground: Cancer Screening in the COVID-19 Era

Lost Ground: Cancer Screening in the COVID-19 Era

by Michael Schubert, PhD | Jan 2, 2024 | Clinical Diagnostics Insider, Testing Trends-dtet, Top of the News-dtet

A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com